{
	"slug": "hyperkalemia",
	"title": "Hyperkalemia",
	"authors": [
		"Michelle Lin, MD"
	],
	"categories": [
		{
			"slug": "endocrinology",
			"name": "Endocrinology"
		},
		{
			"slug": "metabolic",
			"name": "Metabolic"
		},
		{
			"slug": "critical-care",
			"name": "Critical Care"
		}
	],
	"created": "2010/03/12",
	"updates": null,
	"body": "\n# Hyperkalemia\n\n## Potassium regulation\n\n- **Internal K shift:** modulated by insulin, catecholamines, acid-base status\n- **Total body K elimination:** By kidney (95%) and gut (5%)\n\n## Adverse effects of hyperkalemia\n\n- **Cardiac:** Peaked T, wide QRS, loss of P wave, sine wave; although ventricular fibrillation may be first cardiac manifestation\n- **Neuromuscular:** Paresthesias,weakness\n- **Metabolic:** Mild hyperchloremic metabolic acidosis\n\n## Treatment of hyperkalemia\n\n**Mechanism: Cardiac membrane stabilization**\n\n- **Calcium:** Reduces threshold potential in myocytes; check to be sure not on digoxin\n- **Hypertonic saline:** Only for severe hyponatremia in setting of hyperkalemia\n\n**Mechanism: K redistribution**\n\n- **Insulin:** Drives K intracellularly and drops serum K level by 0.6 mmol/L\n- **Beta-agonist:** Drives K intracellularly and 10 mg albuterol drops serum K level by 0.6 mmol/L (20 mg --> K drops by 1 mmol/L); effective in only 60% of patients\n\n**Mechanism: K elimination via kidney/gut**\n\n- **Bicarbonate:** drives K out at distal nephron; best as infusion x 4-6 hrs\n- **Loop diuretic**\n- **Exchange resin** (sodium polystyrene sulfonate): Of minimal to no benefit. \n  - Case reports of colonic necrosis \n\n<table>\n  <tr>\n    <th>Agent</th>\n    <th>Dose</th>\n    <th>Onset</th>\n    <th>Duration</th>\n    <th>Complication</th>\n  </tr>\n  <tr>\n    <td colspan=\"5\"><b>MEMBRANE STABILIZATION</b></td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Ca gluconate 10%</span></td>\n    <td>10 mL over 10 min</td>\n    <td>Immediate</td>\n    <td>30-60 min</td>\n    <td>Hypercalcemia</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Hypertonic 3% NaCl</span></td>\n    <td>50 mL IV push</td>\n    <td>Immediate</td>\n    <td>Unknown</td>\n    <td>Volume overload, hypertonicity</td>\n  </tr>\n  <tr>\n  <td colspan=\"5\"><b>REDISTRIBUTION</b></td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Insulin</span></td>\n    <td>10 units IVP with D50W</td>\n    <td>20 min</td>\n    <td>4-6 hr</td>\n    <td>Hypoglycemia</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Albuterol nebulized</span></td>\n    <td>20 mg/4 cc over 10 min</td>\n    <td>30 min</td>\n    <td>2 hrs</td>\n    <td>Tachycardia</td>\n  </tr>\n  <tr>\n  <td colspan=\"5\"><b>ELIMINATION</b></td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Loop diuretic</span></td>\n    <td>Furosemide 40-80 mg IV</td>\n    <td>15 min</td>\n    <td>2-3 hr</td>\n    <td>Volume depletion</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Sodium bicarbonate</span></td>\n    <td>150 mmol/L IV</td>\n    <td>Hours</td>\n    <td>Infusion</td>\n    <td>Metabolic alkalosis, volume overload</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Kayexalate</span></td>\n    <td>15-30 g</td>\n    <td>>2 hrs</td>\n    <td>4-6 hr</td>\n    <td>Variable efficacy</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Hemodialysis</span></td>\n    <td></td>\n    <td>Immediate</td>\n    <td>3 hrs</td>\n    <td>Arrhythmias</td>\n  </tr>\n</table>\n\n## References\n\n- Weisberg LS. Management of severe hyperkalemia. _Crit Care Med_. 2008; 36:3246-51. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/?term=18936701)]\n"
}